Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates.
Pediatr. Infect. Dis. J., Dec;31(12):1252-1257 (2012)
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.
Biol. Blood Marrow Transplant., Nov;18(11):1656-63 (2012)
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia.
Blood., Jun;119(25):6155-61 (2012)
Massage for children undergoing hematopoietic cell transplantation: a qualitative report.
Evid Based Complement Alternat Med., 2012:792042 (2012)
Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial.
Evid Based Complement Alternat Med., 2012:450150 (2012)
National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-s
Biol. Blood Marrow Transplant., Mar;18(3):334-47 (2012)
Complications of transplant for nonmalignant disorders: autoimmune cytopenias, opportunistic infections, and PTLD.
Biol. Blood Marrow Transplant., Jan;18(1 Suppl):S101-10 (2012)
Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.
Pediatr Blood Cancer., Jul;59(1):11-5 (2012)
Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?
Pediatr Blood Cancer., Jul;59(1):16-20 (2012)
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
Pediatr Blood Cancer., Jul;59(1):21-6 (2012)
NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
Biol. Blood Marrow Transplant., Dec;17(12):1725-38 (2011)
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
Biol. Blood Marrow Transplant., Oct;17(10):1424-7 (2011)
Short tandem repeat and human leukocyte antigen mutations or losses confound engraftment and typing analysis in hematopoietic stem cell transplants.
Hum. Immunol., Jun;72(6):503-9 (2011)
Severe neonatal congenital erythropoietic porphyria.
Pediatr Dermatol., 28(4):416-20 (2011 Jul-Aug)
Radiosensitive severe combined immunodeficiency disease.
Immunol Allergy Clin North Am., Feb;30(1):125-42 (2010)
The tortoise and the hare: slow and steady stem cells win the race.
Leuk. Res., May;34(5):572-3 (2010)
Development of herpes simplex virus stomatitis during receipt of cidofovir therapy.
Clin. Infect. Dis., Oct;49(8):e92-5 (2009)
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
Bone Marrow Transplant., Dec;44(12):805-12 (2009)
Primary graft failure after umbilical cord blood transplant rescued by parental haplocompatible stem cell transplantation.
J. Pediatr. Hematol. Oncol., Apr;31(4):300-3 (2009)
Safety of hematopoietic stem cell transplantation in children less than three years of age.
Pediatr Hematol Oncol., Dec;25(8):705-22 (2008)